Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma
- 16 June 2006
- journal article
- research article
- Published by Elsevier BV in Human Pathology
- Vol. 37 (7), 809-815
- https://doi.org/10.1016/j.humpath.2005.10.018
Abstract
Micropapillary carcinoma (MC) has been well described in other organs, including breast, urinary bladder, lung, ovary, and salivary gland, but has not been described in the large intestine. We compared the clinicopathologic and immunohistochemical findings of MC with those of conventional adenocarcinoma in the large intestine. Fifty-five cases of adenocarcinoma with an MC component were identified among 585 consecutive cases of colorectal cancer at the Asan Medical Center between January 2003 and June 2004 and were compared with 119 cases of conventional adenocarcinoma of colorectum without an MC component. Arrayed tissue blocks were constructed and immunostained for cytokeratin 7 and 20 and CDX2. We also compared the results of MLH-1, MSH-2, p53, and carcinoembryonic antigen immunostainings between the 2 groups. The grade of both MC and conventional adenocarcinoma was mostly moderately differentiated. The proportion of MC ranged from 5% to 80%. The presence but not extent of MC in the primary tumors was associated with more frequent lymphovascular invasion and lymph node (LN) metastases, a greater mean number of positive LNs, and a higher tumor stage with more frequent distant metastases, compared with conventional adenocarcinoma (P < .05). Cytokeratin 7 staining was occasionally observed in both MC (9.1%, 5/55 cases) and conventional adenocarcinoma (13.4%, 16/119 cases). Although MLH-1 and CDX2 expression tended to be lower in conventional adenocarcinoma, none of the immunohistochemical results was significantly different between 2 groups. Recognition of MC component is important as MC appeared to be an aggressive variant of colonic adenocarcinoma and presented at a higher stage, with frequent lymphovascular invasion, LN metastasis, and distant metastasis, compared with conventional adenocarcinoma. The proportion of MC component did not impact the prognosis, and the immunoprofiles of MC were not significantly different from those of conventional adenocarcinoma.This publication has 17 references indexed in Scilit:
- Carcinomas with Micropapillary MorphologyAdvances in Anatomic Pathology, 2004
- Invasive Micropapillary Salivary Duct CarcinomaThe American Journal of Surgical Pathology, 2004
- The Value of Cdx2 Immunostaining in Differentiating Primary Ovarian Carcinomas From Colonic Carcinomas Metastatic to the OvariesInternational Journal of Gynecological Pathology, 2004
- Invasive Micropapillary Carcinoma of the Breast: Are the Pure Forms More Aggressive than the Mixed Forms?The Breast Journal, 2003
- Advanced-Stage Serous Borderline Tumors of the Ovary: A Clinicopathological Study of 49 CasesInternational Journal of Gynecological Pathology, 2003
- Budding as a Risk Factor for Lymph Node Metastasis in pT1 or pT2 Well-Differentiated Colorectal AdenocarcinomaDiseases of the Colon & Rectum, 2002
- Micropapillary Component in Lung AdenocarcinomaThe American Journal of Surgical Pathology, 2002
- Histologic Features Associated with Lymph Node Metastasis in Stage T1 and Superficial T2 Rectal Adenocarcinomas in Abdominoperineal Resection Specimens: Identifying a Subset of Patients for Whom Treatment with Adjuvant Therapy or Completion Abdominoperineal Resection should be Considered After Local ExcisionAmerican Journal of Clinical Pathology, 1999
- Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder Histologic Pattern Resembling Ovarian Papillary Serous CarcinomaThe American Journal of Surgical Pathology, 1994
- Prognostic value of tumor “budding” in patients with colorectal cancerDiseases of the Colon & Rectum, 1993